Apyx Medical Co. (NASDAQ:APYX) Sees Large Drop in Short Interest

Apyx Medical Co. (NASDAQ:APYX) was the target of a large decline in short interest in August. As of August 31st, there was short interest totalling 265,100 shares, a decline of 10.7% from the August 15th total of 296,900 shares. Based on an average daily volume of 34,900 shares, the short-interest ratio is currently 7.6 days. Currently, 0.9% of the company’s stock are sold short.

Institutional Investors Weigh In On Apyx Medical

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Silverberg Bernstein Capital Management LLC raised its position in Apyx Medical by 1.2% in the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 621,387 shares of the company’s stock valued at $845,000 after buying an additional 7,507 shares during the last quarter. Kingsview Wealth Management LLC acquired a new position in shares of Apyx Medical during the 4th quarter worth approximately $32,000. ProVise Management Group LLC acquired a new position in shares of Apyx Medical during the 4th quarter worth approximately $35,000. Commonwealth Equity Services LLC increased its position in shares of Apyx Medical by 2.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 511,561 shares of the company’s stock worth $685,000 after purchasing an additional 14,481 shares during the last quarter. Finally, Perkins Capital Management Inc. increased its position in shares of Apyx Medical by 7.0% during the 1st quarter. Perkins Capital Management Inc. now owns 228,500 shares of the company’s stock worth $311,000 after purchasing an additional 15,000 shares during the last quarter. Institutional investors and hedge funds own 55.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, JMP Securities reiterated a “market perform” rating on shares of Apyx Medical in a report on Monday.

Apyx Medical Trading Down 2.8 %

NASDAQ:APYX opened at $1.05 on Thursday. Apyx Medical has a fifty-two week low of $0.97 and a fifty-two week high of $3.95. The company has a debt-to-equity ratio of 2.26, a current ratio of 5.33 and a quick ratio of 4.45. The stock has a market capitalization of $36.38 million, a PE ratio of -1.59 and a beta of 1.20. The business’s 50-day simple moving average is $1.26 and its 200-day simple moving average is $1.43.

Apyx Medical (NASDAQ:APYX) last released its quarterly earnings data on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.18) by ($0.01). Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. The business had revenue of $12.15 million for the quarter, compared to the consensus estimate of $12.67 million. During the same quarter last year, the firm earned ($0.11) EPS. Sell-side analysts expect that Apyx Medical will post -0.69 earnings per share for the current fiscal year.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.